Screening for Preeclampsia
Welcome to this educational course on screening for preeclampsia in the first, second and third trimesters of pregnancy.
The course will cover:
- Background to PE, including definition, prevalence, implications, and pathogenesis
- Prevention of PE, by such measures as bed rest, dietary manipulations and use of low dose aspirin
- Prediction of PE by a combination of maternal characteristics and history and biochemical and biophysical markers
- Performance of screening for PE in the first, second and third trimesters of pregnancy
- Stratification of pregnancy management
Screening at 11-13 weeks identifies a high-risk group where administration of aspirin can substantially reduce the incidence of preterm preeclampsia.
Screening during the second and third trimesters identifies a high-risk group where intensive monitoring could lead to early diagnosis of preeclampsia and reduction in the adverse perinatal events associated with the disease.
The course lasts for about 1 hour, but it does not need to be completed in a single session.
Upon completing the course, you will obtain a certificate of attendance.
The course is mandatory as part of the FMF Certification in Screening for Preeclampsia.